The mission of The DOLF Project is to develop and test improved treatments for onchocerciasis and lymphatic filariasis that will enhance efforts to control and eliminate these important neglected tropical diseases.

NEWS & EVENTS


Welcome to DOLF’s new Postdoctoral Research Associate- Dr. Adebiyi Adeniran

Welcome to DOLF’s new Postdoctoral Research Associate- Dr. Adebiyi Adeniran

Adebiyi is a molecular entomologist and molecular parasitologist with over a decade of Neglected Tropical Disease (NTD) research and control program experience in sub-Saharan Africa and in Mexico. Adebiyi has  previously worked as the Regional Technical Lead for NTD diagnostics for Sightsavers UK, where he provided technical and advisory support to NTD control programs in […]
DOLF and DOLF-Affiliated Researcher Presentations at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference

DOLF and DOLF-Affiliated Researcher Presentations at the American Society of Tropical Medicine and Hygiene (ASTMH) Annual Conference

Monday, October 31, 2022 Presenter Session Name # Abstract Title Time Location Catherine Bjerum Session 9 – Filariasis – Clinical, Immunology, Diagnostics 35 Moxidectin combination therapy for lymphatic filariasis is superior to ivermectin plus albendazole for clearance of microfilaremia at 12 months post-treatment 8:00 – 8:15 am Convention Center – Room 611/612 Peter Fischer Session […]

Eleven DOLF Project publications on triple drug (IDA) mass drug administration for elimination of lymphatic filariasis have now been bundled as a PLoS Collection

PloS “Collections” are useful for readers and researchers alike, because provide easy access to related articles on high priority topics that have been published in PLoS journals at different times. This collection (published June 16, 2022) focuses on clinical trials and community studies of the safety, efficacy, and acceptability of the triple drug regimen IDA […]
  • Cote d'Ivoire